(Q44359154)

2 December 2017

Positron emission tomographic analysis of dose-dependent NAD-299 binding to 5-hydroxytryptamine-1A receptors in the human brain (English)

1 reference

2 December 2017

5

Christer Halldin

1 reference

2 December 2017

6

Lars Farde

1 reference

2 December 2017

Bengt Andrée

1

1 reference

2 December 2017

Ann Hedman

series ordinal

2

1 reference

2 December 2017

Seth-Olav Thorberg

series ordinal

3

1 reference

2 December 2017

Dag Nilsson

series ordinal

4

1 reference

2 December 2017

11 March 2003

1 reference

2 December 2017

9

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

2 December 2017

167

1 reference

2 December 2017

1

1 reference

2 December 2017

37-45

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-002-1355-0

2 December 2017

0 references

cites work

Pindolol binding to 5-HT1A receptors in the human brain confirmed with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Distribution, morphology and number of monoamine-synthesizing and substance P-containing neurons in the human dorsal raphe nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Current advances and trends in the treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Early localization of mRNA coding for 5-HT1A receptors in human brain during development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Parametric imaging of ligand-receptor binding in PET using a simplified reference region model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

5-HT receptors: subtypes and second messengers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Simplified reference tissue model for PET receptor studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Comparison of methods for analysis of clinical [11C]raclopride studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Differential regional antagonism of 8-OH-DPAT-induced decrease in serotonin synthesis by two 5-HT1A receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Efficacy of treatment with trazodone in combination with pindolol or fluoxetine in major depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

The role of serotonin in antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

A double-blind, randomized, placebo-controlled trial of pindolol augmentation in depressive patients resistant to serotonin reuptake inhibitors. Grup de Recerca en Trastorns Afectius.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

beta-blocker binding to human 5-HT(1A) receptors in vivo and in vitro: implications for antidepressant therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

PET-examination and metabolite evaluation in monkey of [(11)C]NAD-299, a radioligand for visualisation of the 5-HT(1A) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

In vivo labelling of the mouse brain 5-hydroxytryptamine1A receptor with the novel selective antagonist 3H-NAD-299.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

How long should pindolol be associated with paroxetine to improve the antidepressant response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

Exquisite delineation of 5-HT1A receptors in human brain with PET and [carbonyl-11C]WAY-100635

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-002-1355-0

The role of serotonin in depression and anxiety.

21 January 2018

1 reference

12 December 2020

D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients

1 reference

12 December 2020

Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial. Réseau de Recherche et d'Expérimentation Psychopharmacologique

1 reference

12 December 2020

The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.

1 reference

12 December 2020

Pindolol augmentation of treatment-resistant depressed patients.

1 reference

12 December 2020

Faster onset of action of fluvoxamine in combination with pindolol in the treatment of delusional depression: a controlled study

1 reference

12 December 2020

Quantitative analyses of carbonyl-carbon-11-WAY-100635 binding to central 5-hydroxytryptamine-1A receptors in man.

1 reference

12 December 2020

PET-Determination of robalzotan (NAD-299) induced 5-HT(1A) receptor occupancy in the monkey brain

1 reference

12 December 2020

Drug action at the 5-HT1A receptor in vivo: autoreceptor and postsynaptic receptor occupancy examined with PET and [carbonyl-11C]WAY-100635

1 reference

12 December 2020

The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain

1 reference

12 December 2020

The ECAT EXACT HR: performance of a new high resolution positron scanner.

1 reference

12 December 2020

Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635

1 reference

12 December 2020

Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment

1 reference

12 December 2020

Two actions are better than one: avoiding self-inhibition of serotonergic neurones enhances the effects of serotonin uptake inhibitors

1 reference

12 December 2020

Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial

1 reference

12 December 2020

Head fixation device for reproducible position alignment in transmission CT and positron emission tomography

1 reference

12 December 2020

Extracellular serotonin levels change with behavioral state but not with pyrogen-induced hyperthermia

1 reference

12 December 2020

Oral administration of NNC 756--a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man

1 reference

12 December 2020

Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression

1 reference

12 December 2020

Pindolol Induces a Rapid Improvement of Depressed Patients Treated With Serotonin Reuptake Inhibitors

1 reference

12 December 2020

Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine

1 reference

12 December 2020

Dopamine receptor occupancy and plasma haloperidol levels

1 reference

12 December 2020

Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency

1 reference

12 December 2020

Single and multiple dose pharmacokinetics of pindolol

1 reference

12 December 2020

10.1007/S00213-002-1355-0

Identifiers

DOI

1 reference

2 December 2017

1 reference